Research and Development

Showing 15 posts of 9596 posts found.

Intercell Biomedical appoints site director

October 6, 2010 Manufacturing and Production, Research and Development Intercell, appointment, research and development

Austrian biotech Intercell Biomedical has appointed Eric Frings as site director of its Livingston, Scotland operations.He joins the firm from …

Novartis drops two drug candidates, takes $600 million hit

October 6, 2010 Research and Development Human Genome Sciences, Novartis, candidiasis, hepatitis

Novartis will incur a charge of nearly $600 million after it halted development of investigational drugs for hepatitis C and …
GSK’s Seretide/Advair

New COPD and asthma treatments jostle for market space

October 6, 2010 Research and Development, Sales and Marketing COPD, Daxas, Onbrez Breezhaler, Revolair, asthma

Competition in the field of COPD and asthma is hotting up, with new data for several key treatments recently unveiled. …

Talking R&D: eCTD challenges

October 6, 2010 Manufacturing and Production, Research and Development Talking R&D, eCTD, eCTD submissions

The eCTD was of course developed by the ICH (International Conference on Harmonisation) Expert Working Group to make it easier, …

GSK takes stake in biotech spin-out

October 5, 2010 Research and Development, Sales and Marketing Convergence, GlaxoSmithKline, funding

GlaxoSmithKline has taken a stake in a newly-launched biotech company in return for handing it two clinical compounds. The pharma …

Svend Andersen to lead Hospira in Europe

October 5, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Hospira, appointment, manufacturing and production, research and development, sales and marketing

US global specialty pharmaceutical company Hospira has appointed Svend Andersen to lead its operations in Europe with effect from 1 …

Talking R&D: Evolving technical standards

October 5, 2010 Manufacturing and Production, Research and Development Talking R&D, eCTD, eCTD submissions

The European Union (EU) Module 1 specification works in parallel with the ICH eCTD Specification. It was first introduced in …

Sanofi makes hostile offer for Genzyme

October 4, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Sanofi-Aventis’ courtship dance around Genzyme has turned more aggressive with an offer – made over the heads of Genzyme’s board …

GSK drops herpes vaccine

October 4, 2010 Research and Development, Sales and Marketing GlaxoSmithKline, Simplirix, herpes, sexual health

Poor phase III results have forced GlaxoSmithKline to halt development of its Simplirix vaccine for women with genital herpes. The …

Talking R&D: US regulatory guidelines

October 4, 2010 Manufacturing and Production, Research and Development Talking R&D, eCTD submissions

Recent speculation surrounding current diabetes drugs and their long term effect on cardiovascular health has heads spinning in the pharmaceutical …

AZ-BMS diabetes drug impresses in phase III trials

October 1, 2010 Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes

AstraZeneca and Bristol Myers Squibb’s potential first-in-class diabetes drug dapagliflozin has shown strong results in a late stage trial. It …

FDA unveils new trial data rules

October 1, 2010 Research and Development FDA, clinical trials, pharmacovigilance

The FDA has clarified its rules on what safety information must be reported during clinical trials of investigational drugs and …

BMS poaches AZ’s head of global medical affairs

October 1, 2010 Research and Development, Sales and Marketing BMS, appointment, research and development, sales and marketing

Bristol-Myers Squibb has appointed Dr Rick Lones as executive medical director in the UK. He joins BMS from AstraZeneca, where …

Sanofi signs $2.2bn CRO deal

October 1, 2010 Research and Development CRO, Covance, Sanofi-Aventis

Sanofi-Aventis has signed a major deal to contract out a wide range of drug development and laboratory services as part …

ClinTec recruits former Wyeth VP

September 29, 2010 Research and Development ClinTec, appointment, research and development

Glasgow, UK-based contract research organisation ClinTec has expanded its US operations with the appointment of new executive vice president Dr …
The Gateway to Local Adoption Series

Latest content